StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

VitaSpring Biomedical's operating cash flow for the twelve months ending Jul 31, 2026 was $10.57K. For fiscal 2026 it was -$2.69K. The highest annual figure on record is $401 in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jan 31, 2026-$2.69K–
FY2025Jan 31, 2025-$14.68K–
FY2024Jan 31, 2024-$34.92K–
FY2023Jan 31, 2023-$77.56K–
FY2022Jan 31, 2022-$269.63K–
FY2021Jan 31, 2021-$42.13K–
FY2020Jan 31, 2020-$105–
FY2019Jan 31, 2019-$34.25K-8640.6%
FY2018Jan 31, 2018$401–
FY2017Jan 31, 2017-$4.05K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jul 31, 2026$5.20K–
Q1 FY2027CQ1 2026Apr 30, 2026$6.08K–
Q4 FY2026CQ4 2025Jan 31, 2026$124–
Q3 FY2026CQ3 2025Oct 31, 2025-$839–
Q2 FY2026CQ2 2025Jul 31, 2025-$1.19K–
Q1 FY2026CQ1 2025Apr 30, 2025-$787–
Q4 FY2025CQ4 2024Jan 31, 2025-$1.79K–
Q3 FY2025CQ3 2024Oct 31, 2024-$6.44K–
Q2 FY2025CQ2 2024Jul 31, 2024-$2.42K-1387.8%
Q1 FY2025CQ1 2024Apr 30, 2024-$4.02K–
Q4 FY2024CQ4 2023Jan 31, 2024-$2.62K-146.8%
Q3 FY2024CQ3 2023Oct 31, 2023-$4.55K-284.8%
Q2 FY2024CQ2 2023Jul 31, 2023$188–
Q1 FY2024CQ1 2023Apr 30, 2023-$27.94K–
Q4 FY2023CQ4 2022Jan 31, 2023$5.61K–
Q3 FY2023CQ3 2022Oct 31, 2022$2.46K-99.3%
Q2 FY2023CQ2 2022Jul 31, 2022-$57.56K–
Q1 FY2023CQ1 2022Apr 30, 2022-$28.06K-107.8%
Q4 FY2022CQ4 2021Jan 31, 2022-$27.98K–
Q3 FY2022CQ3 2021Oct 31, 2021$376.80K–
Q2 FY2022CQ2 2021Jul 31, 2021-$977.31K–
Q1 FY2022CQ1 2021Apr 30, 2021$358.86K+40085.8%
Q4 FY2021CQ4 2020Jan 31, 2021-$42.86K–
Q3 FY2021CQ3 2020Oct 31, 2020$0–
Q2 FY2021CQ2 2020Jul 31, 2020-$165–
Q1 FY2021CQ1 2020Apr 30, 2020$893-41.1%
Q4 FY2020CQ4 2019Jan 31, 2020-$134-104.3%
Q3 FY2020CQ3 2019Oct 31, 2019-$284–
Q2 FY2020CQ2 2019Jul 31, 2019-$1.20K–
Q1 FY2020CQ1 2019Apr 30, 2019$1.52K–
Q4 FY2019CQ4 2018Jan 31, 2019$3.13K-35.0%
Q3 FY2019CQ3 2018Oct 31, 2018-$19.79K–
Q2 FY2019CQ2 2018Jul 31, 2018-$14.56K–
Q1 FY2019CQ1 2018Apr 30, 2018-$3.03K–
Q4 FY2018CQ4 2017Jan 31, 2018$4.82K–
Q3 FY2018CQ3 2017Oct 31, 2017-$554–
Q2 FY2018CQ2 2017Jul 31, 2017-$1.60K–
Q1 FY2018CQ1 2017Apr 30, 2017-$2.27K–

More VitaSpring Biomedical figures

See a number that looks wrong?